These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29053731)

  • 1. Determination of μ-, δ- and κ-opioid receptors in forebrain cortex of rats exposed to morphine for 10 days: Comparison with animals after 20 days of morphine withdrawal.
    Ujcikova H; Hlouskova M; Cechova K; Stolarova K; Roubalova L; Svoboda P
    PLoS One; 2017; 12(10):e0186797. PubMed ID: 29053731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of adenylylcyclases I and II induced by long-term adaptation of rats to morphine fades away 20 days after morphine withdrawal.
    Ujcikova H; Dlouha K; Roubalova L; Vosahlikova M; Kagan D; Svoboda P
    Biochim Biophys Acta; 2011 Dec; 1810(12):1220-9. PubMed ID: 22001437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of protein composition of rat hippocampus exposed to morphine for 10 days; comparison with animals after 20 days of morphine withdrawal.
    Ujcikova H; Cechova K; Jagr M; Roubalova L; Vosahlikova M; Svoboda P
    PLoS One; 2020; 15(4):e0231721. PubMed ID: 32294144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of protein composition of rat forebrain cortex exposed to morphine for 10days; comparison with animals exposed to morphine and subsequently nurtured for 20days in the absence of this drug.
    Ujcikova H; Vosahlikova M; Roubalova L; Svoboda P
    J Proteomics; 2016 Aug; 145():11-23. PubMed ID: 26921832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofilament proteins and cAMP pathway in brains of mu-, delta- or kappa-opioid receptor gene knock-out mice: effects of chronic morphine administration.
    García-Sevilla JA; Ferrer-Alcón M; Martín M; Kieffer BL; Maldonado R
    Neuropharmacology; 2004 Mar; 46(4):519-30. PubMed ID: 14975676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the brain kappa-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol.
    Fan LW; Tien LT; Tanaka S; Ma T; Chudapongse N; Sinchaisuk S; Rockhold RW; Ho IK
    Neuroscience; 2003; 121(4):1063-74. PubMed ID: 14580956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of mitogen-activated protein kinase kinases (MEK1/2) by mu-, delta- and kappa-opioid receptor agonists in the rat brain: regulation by chronic morphine and opioid withdrawal.
    Asensio VJ; Miralles A; García-Sevilla JA
    Eur J Pharmacol; 2006 Jun; 539(1-2):49-56. PubMed ID: 16678156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of repeated administration of morphine, cocaine and ethanol on mu and delta opioid receptor density in the nucleus accumbens and striatum of the rat.
    Turchan J; Przewłocka B; Toth G; Lasoń W; Borsodi A; Przewłocki R
    Neuroscience; 1999; 91(3):971-7. PubMed ID: 10391475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracerebroventricular administration of CYX-6, a potent μ-opioid receptor agonist, a δ- and κ-opioid receptor antagonist and a biased ligand at μ, δ & κ-opioid receptors, evokes antinociception with minimal constipation and respiratory depression in rats in contrast to morphine.
    Imam MZ; Kuo A; Ghassabian S; Cai Y; Qin Y; Li T; Smith MT
    Eur J Pharmacol; 2020 Mar; 871():172918. PubMed ID: 31958457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.
    Yadlapalli JSK; Ford BM; Ketkar A; Wan A; Penthala NR; Eoff RL; Prather PL; Dobretsov M; Crooks PA
    Pharmacol Res; 2016 Nov; 113(Pt A):335-347. PubMed ID: 27637375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine-6-O-beta-D-glucuronide but not morphine-3-O-beta-D-glucuronide binds to mu-, delta- and kappa- specific opioid binding sites in cerebral membranes.
    Löser SV; Meyer J; Freudenthaler S; Sattler M; Desel C; Meineke I; Gundert-Remy U
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):192-7. PubMed ID: 8857597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term adaptation to high doses of morphine causes desensitization of mu-OR- and delta-OR-stimulated G-protein response in forebrain cortex but does not decrease the amount of G-protein alpha subunits.
    Bourova L; Vosahlikova M; Kagan D; Dlouha K; Novotny J; Svoboda P
    Med Sci Monit; 2010 Aug; 16(8):BR260-70. PubMed ID: 20671607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
    Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
    Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mu- and delta-opioid receptor antagonists precipitate similar withdrawal phenomena in butorphanol and morphine dependence.
    Feng YZ; Zhang T; Tokuyama S; Zhu H; Rockhold RW; Ho IK
    Neurochem Res; 1996 Jan; 21(1):63-71. PubMed ID: 8833225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
    Broadbear JH; Sumpter TL; Burke TF; Husbands SM; Lewis JW; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2000 Sep; 294(3):933-40. PubMed ID: 10945843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene.
    Matthes HW; Maldonado R; Simonin F; Valverde O; Slowe S; Kitchen I; Befort K; Dierich A; Le Meur M; Dollé P; Tzavara E; Hanoune J; Roques BP; Kieffer BL
    Nature; 1996 Oct; 383(6603):819-23. PubMed ID: 8893006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid-receptor (OR) signaling cascades in rat cerebral cortex and model cell lines: the role of plasma membrane structure.
    Ujčíková H; Brejchová J; Vošahlíková M; Kagan D; Dlouhá K; Sýkora J; Merta L; Drastichová Z; Novotný J; Ostašov P; Roubalová L; Parenti M; Hof M; Svoboda P
    Physiol Res; 2014; 63(Suppl 1):S165-76. PubMed ID: 24564656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The mu, delta and kappa properties of various opioids].
    Ohta S; Niwa M; Nozaki M; Hattori M; Shimonaka H; Dohi S
    Masui; 1995 Sep; 44(9):1228-32. PubMed ID: 8523655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative autoradiographic demonstration of changes in binding to delta opioid, but not mu or kappa receptors, in chick forebrain 30 minutes after passive avoidance training.
    Csillag A; Stewart MG; Székely AD; Maglóczky Z; Bourne RC; Steele RJ
    Brain Res; 1993 Jun; 613(1):96-105. PubMed ID: 8394181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of opiate drugs on Fas-associated protein with death domain (FADD) and effector caspases in the rat brain: regulation by the ERK1/2 MAP kinase pathway.
    García-Fuster MJ; Miralles A; García-Sevilla JA
    Neuropsychopharmacology; 2007 Feb; 32(2):399-411. PubMed ID: 16482086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.